The American Diabetes Association has updated its Standards of Care to recommend continuous glucose monitoring (CGM) for all newly diagnosed type 2 diabetes patients. The change reflects evidence that ...

A landmark trial has confirmed real-time continuous glucose monitoring (CGM) improves blood sugar control in type 2 diabetes, while new wearable sensors promise broader, continuous biomarker tracking.

Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...

Injuries, early starts and a busy schedule – Norton’s approach shows how to build endurance when training isn’t perfect ...

Dexcom has opted not to raise its FY26 revenue outlook due to the current geopolitical environment.

Medical device company DexCom (NASDAQ:DXCM) reported Q1 CY2026 results exceeding the market’s revenue expectations, with ...

DexCom (NASDAQ: DXCM) held its first-quarter earnings conference call on Thursday. Below is the complete transcript from the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Dexcom. The company’s shares closed yesterday at $59.55. Claim 55% Off TipRanks.

Momentum is building in Washington for the long-awaited CLARITY Act, with JPMorgan (JPM) pointing to signs that negotiations may be nearing a breakthrough. JPMorgan said discussions among lawmakers ...

Polymarket odds for the CLARITY Act passing in 2026 have dropped from 82% to 60%, with Chairman Tim Scott saying three unresolved issues still need weeks to work out before the committee can vote.